Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes. - Greenbaum CJ; Long SA; Gitelman SE; Gaglia JL; Daniels M; Brusko TM; Lord S; Bundy BN; Krischer JP; Haller MJ; Steck AK; DiMeglio LA; et al. (Diabetes, 2026)